KIM-SON HOA NGUYEN NPI 1831357029

NPI Details

Kim-son Hoa Nguyen is a medical oncology internal medicine in Stanford, CA with 18 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Kim-son Hoa Nguyen NPI is 1831357029. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: HARVARD MEDICAL SCHOOL
Graduation Year:2007

The provider's business location address is:

300 PASTEUR DR
STANFORD, CA
ZIP 94305-200
Phone: (650) 723-4000

The NPI 1831357029 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1459)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, pemetrexed, not otherwise specified, 10 mg (HCPCS:J9305)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Collection of blood sample from implanted device (HCPCS:36591)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)

The enumeration date for this NPI number is 5/25/2008 and was last updated on 4/15/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: